Bios Line Holding
Overview
Bios Line Holding is a private investment firm based in Italy, specializing in the biotech and life sciences sectors. The firm is dedicated to investing in innovative healthcare solutions, aiming to enhance the well-being of individuals through strategic partnerships and investments. Established in 2022, Bios Line Holding operates primarily within Italy, focusing on early-stage ventures and growth opportunities in the biotechnology and life sciences industries. The firm's investment strategy emphasizes supporting companies that are developing cutting-edge healthcare solutions, with a particular interest in those that integrate traditional knowledge with scientific innovation. Bios Line Holding's portfolio includes investments in companies such as MgShell and Freedome, reflecting its commitment to fostering innovation in the healthcare sector. The firm maintains a strong emphasis on ethical sustainability and environmental responsibility, aligning with its mission to invest in a better future. By leveraging its expertise and resources, Bios Line Holding seeks to drive positive change in the healthcare industry, supporting the development of products and services that contribute to improved health outcomes and quality of life.
Reach Bios Line Holding directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Bios Line Holding
What sectors does Bios Line Holding invest in?
Bios Line Holding invests in Healthcare, Life Sciences and Biotechnology, and is based in Padua, Italy. Bios Line Holding is listed as a private investment firm in the ConnectSafely investor database.
What stage does Bios Line Holding invest at?
Bios Line Holding backs companies at Seed, Early Stage and Growth.
Which regions does Bios Line Holding invest in?
Bios Line Holding invests across Italy.
Last updated · Source: ConnectSafely investor database
